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Keratoconus provides a decrease of quality of life to the patients who suﬀer from it. The treatment used as well as the method to
correct the refractive error of these patients may inﬂuence on the impact of the disease on their quality of life. The purpose of
this review is to describe the evidence about the conservative surgical treatment for keratoconus aiming to therapeutic and
refractive eﬀect. The visual rehabilitation for keratoconic corneas requires addressing three concerns: halting the ectatic process,
improving corneal shape, and minimizing the residual refractive error. Cross-linking can halt the disease progression,
intrastromal corneal ring segments can improve the corneal shape and hence the visual quality and reduce the refractive error,
PRK can correct mild-moderate refractive error, and intraocular lenses can correct from low to high refractive error associated
with keratoconus. Any of these surgical options can be performed alone or combined with the other techniques depending on
what the case requires. Although it could be considered that the surgical option for the refracto-therapeutic treatment of the
keratoconus is a reality, controlled, randomized studies with larger cohorts and longer follow-up periods are needed to
determine which refractive procedure and/or sequence are most suitable for each case.
1. Introduction
Keratoconus is a bilateral chronic, asymmetric, progressive
ectatic condition, in which the cornea assumes a conical
shape that induces abnormalities such as high regular and
irregular astigmatism and increased higher order aberrations
(HOAs), with adverse eﬀects on the visual quality of the
patients concerned [1, 2]. It is well established that keratoco-
nus appears in the adolescence and its progression is more
acute up to the third decade of life [2]. A recent study shows
that the estimated prevalence of keratoconus was 265 cases
per 100,000 [3]. This study also showed that the prevalence
was higher in men than in women [3]. Keratoconus provides
a decrease of quality of life to the patients who suﬀer from
it [4]. Moreover, it has been reported that despite its low
prevalence and that it unusually leads to blindness, its impact
on the public health is much higher than expected [5].
The method used to correct the refractive error of these
patients may also inﬂuence on the impact of the disease on
their quality of life. It has been reported that rigid gas perme-
able contact lenses (RPGCLs) minimize the impact of the
keratoconus on the quality of life of the patients compared
with spectacles [6]. Perhaps, the higher corrected distance
visual acuity (CDVA) with RPGCL and the spectacle inde-
pendency could explain these ﬁndings. Although keratoconus
was historically considered as a noninﬂammatory condition,
recent researchers revealed increased levels of inﬂammatory
mediators in tears of keratoconus patients without clinical
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signs of inﬂammation [7]. Hence, it has been suggested that
keratoconus should not be classiﬁed as a noninﬂammatory
disorder and even that the pathogenesis of keratoconus pro-
gression could include chronic inﬂammatory events [8, 9]. It
should be noted that contact lens wear is intrinsically inﬂam-
matory [10]. Lema et al. [11] reported that wearing RPGCL
provides an increased level of proinﬂammatory mediators in
the tears of patients with keratoconus. So, the question here
is whether it is possible to improve the quality of life of
keratoconus patients without using CLs or spectacles.
de Freitas Santos Paranhos et al. [12] reported that
intrastromal corneal ring segment (ICRS) implantation not
only improved the visual quality of the keratoconus patients,
but also had a positive impact on their quality of life. How-
ever, in this study, it was not reported whether after ICRS
implantation the patients were ﬁtted with contact lenses or
spectacle correction.
Generally, the visual rehabilitation for keratoconic cor-
neas requires addressing three concerns: halting the ectatic
process, improving corneal shape, and minimizing the resid-
ual refractive error. The treatment would depend, among
other factors, on each of these concerns and its inﬂuence on
the disease and quality of vision of the patient. That is,
keratoconus is progressing or not, the cornea shape is very
irregular with a high level of higher order aberrations
(HOAs) and poor CDVA or not, and ﬁnally the degree of
associated ametropia. The purpose of this review is to
describe the evidence about the conservative surgical treat-
ment for keratoconus aiming to therapeutic and refractive
eﬀect. We have not included the keratoplasty in this review,
which is the surgical procedure for advanced keratoconus.
The preoperative clinical features, the complexity of the
procedure, and the potential long-term complications make
the objectives of this procedure go beyond refractive ones.
2. No Combined Procedure
2.1. Excimer Laser Surgery. Most of the studies of corneal
refractive surgery in keratoconus are in combination with
other treatments, which aim to stabilize the disease (these
studies will be discussed below). In order to carry out the
literature search, we used the following databases: PubMed
(United States National Library of Medicine), Web of Science
(Thomson Reuters), Embase (Reed Elsevier Properties SA),
and Scopus (Elsevier). The search used a combination of the
following keywords: (keratoconus OR keratoconic) AND
(PRK OR LASIK OR excimer laser surgery). The search was
limited to English language publications and peer-reviewed
scientiﬁc reports. We found 13 articles, which met with our
inclusion criteria, that is, corneal refractive surgery for the
treatment of the refractive correction in keratoconus. We
excluded the studies in which the corneal refractive surgery
was combined with other techniques. In most of these
publications, the level of scientiﬁc evidence of the studies
was IV (according to the National Health and Medical
Research Council guidelines for interventional studies
[13]). This level represents the case series studies with
preoutcomes and postoutcomes, and it provides the lowest
level of scientiﬁc evidence.
There was only one report, which studied the treatment
keratoconus with laser in situ keratomileusis (LASIK) [14].
Patients with moderate or mild keratoconus, stable refraction
for at least 2 years, and age ranged from 31 to 74 years were
analysed. Only 16 eyes were studied, and 3 eyes required
keratoplasty after LASIK. In addition, there were eyes that
lost visual acuity over the follow-up period, suggesting that
the ectasia was progressing.
Another important question about this article is whether
all cases included were really keratoconus. This paper was
published in 1999, and it is likely that some cases diagnosed
as mild keratoconus, with the current advanced technology,
would not have been diagnosed as keratoconus, a false
positive. In summary, it seems that LASIK should not be con-
sidered for patients with keratoconus. Several studies [15–24]
have reported the outcomes of photorefractive keratectomy
(PRK) in keratoconus suspects, fruste form or mild-
moderate keratoconus. In all studies, the disease was stable
at the moment of the surgery. Mortensen and Ohrstrom in
1994 [15] treated with PRK ﬁve keratoconus that were going
to undergo PKP. In four eyes, there was a reduction of the
astigmatism and an increase of the visual acuity, avoiding
the need for PKP. The authors conﬁrmed these results in a
study published 4 years later, with a larger sample and longer
follow-up in primary keratoconus [16]. In this study, none of
the eyes showed a disease progression after PRK. Sun et al.
[17], in a retrospective study, compared the refractive out-
comes after PRK in 5 keratoconus-suspected eyes with those
in healthy eyes. The refractive outcomes were comparable in
both groups. However, it is important to note that only 5
keratoconus-suspected eyes were analysed. Two more recent
papers studied the long-term results of PRK in keratoconus
suspects [18, 19]. In the ﬁrst one [18], 12 keratoconus-
suspected eyes of 6 patients were included and the follow-up
was 4 years. The second one [19] analysed 62 eyes of 42
patients; the mean of follow-up was 4.8± 1.4 years. Both stud-
ies concluded that PRK in eyes with suspected keratoconus,
carefully selected, might be a safe and eﬀective procedure for
reducing or eliminating myopia and/or astigmatism. Two
studies evaluated the PRK in patients with mild to moderate
stable keratoconus [20, 21]. Chelala et al. [20] in a ﬁve-year
follow-up study analysed the visual outcomes of PRK in 119
eyes with grade 1-2 keratoconus according to Amsler-
Krumeich classiﬁcation. 79 eyes (66.3%) had an uncorrected
distance visual acuity (UDVA) of 20/20 at 5 years of follow-
up. Only two eyes (1.7%) showed progression of the disease
at 5 years of follow-up. In the Khakshoor et al. [21] study,
38 stable keratoconus (grades I-II, Amsler-Krumeich) of 21
patients over 40 years old were recruited. At the last follow-
up visit, in 22 eyes, the UDVA was 20/20 and in 8 eyes
20/25. These authors suggested that a residual central cor-
neal thickness higher than 450 μm seems to be suﬃcient
to prevent the disease progression. Kasparova and Kasparov
[22] combined PRK with phototherapeutic keratotectomy
(PTK) to treat primary keratoconus. They reported good
visual and refractive outcomes, although progression of
the disease was reported in six eyes (8.6%). Finally,
topography-guided [25] and wavefront-guided PRK [26]
appears to be safe and eﬀective to reduce the corneal
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aberrations and improve the visual quality in keratoconus
suspects and mild to moderate keratoconus.
The thresholds of the ablation amount and residual
corneal thickness are a key point for a safe ablation. In
Bilgihan et al.’s study [18], the residual stroma was thicker
than 400μm in all eyes at the completion of stromal ablation.
Kasparova and Kasparov [22] recommended a minimal
corneal thickness> 500μm and a residual corneal thick-
ness≥ 450μm. Koller et al. [23], Chelala et al. [20], and Guedj
et al. [19], in their respective studies, also kept a minimum
residual corneal thickness of ≥450μm. Khakshoor et al.
[21] in a group of keratoconic patients with a mean age of
44 years old reported safe outcomes maintaining a residual
corneal thickness≥ 400μm. The authors suggested that, as
the cornea is much more stiﬀness in older patients due to
natural collagen cross-linking, the residual corneal thickness
can be thinner.
From these studies, it seems that PRK in mild to moder-
ate stable keratoconus might be an eﬀective procedure for
improving UDVA in patients with mild refractive errors.
Despite these encouraging results of PRK, it should be taken
with caution. Firstly, the evidence level of the studies was low;
most of the studies were conducted in the 1990s or early
2000s. Some of these studies included keratoconus suspects
or early keratoconus. Maybe, with the current technological
advances, some of these cases would have been classiﬁed as
healthy eyes (false positives).
2.2. Phakic Intraocular Lenses (pIOLs). Phakic intraocular
lens can be implanted either in the anterior chamber (AC
pIOL) or in the posterior chamber (PC pIOL). Both oﬀer cor-
rection of high spherical and cylinder errors. The literature
search was using the terms “(keratoconus OR keratoconic)
AND (ICL OR implantable Collamer OR phakic intraocular
lens)” in the following databases: PubMed, Web of Science,
Embase, and Scopus. We limited the search to English
language and peer-reviewed publications. We found 18 arti-
cles, which met with our inclusion criteria, that is, phakic
intraocular lens implantation in keratoconus. We excluded
the studies in which this procedure was combined with other
techniques. Six articles studied AC pIOLs [27–32] and 9 PC
pIOLs [33–41], and 1 was a comparative study between both
[42]. Table 1 summarizes the main visual and refractive out-
comes reported after AC pIOL. The reduction in refractive
error is accompanied by a great improvement in UDVA,
where data are available, and in CDVA (range 0.08 to 0.2 dec-
imal scale). Overall, the studies suggest good visual and
refractive outcomes. However, it should be noted that the
number of cases analysed in these studies was low and the
largest series included 36 eyes. Furthermore, it is well known
that one of the main complications with AC pIOL is the
endothelial loss [43]; hence, further studies with more cases
and longer term follow-up should be carried out to assess
the safety of this procedure in keratoconus patients. In a
retrospective study comparing the visual and refractive out-
comes of AC and PC pIOLs, Alió et al. [42] reported that
both modalities are a suitable refractive surgical option for
stable keratoconus. Table 2 summarizes the visual and
refractive outcomes after PC pIOLs. According to these
studies, more than 70% of the cases, the spherical equiva-
lent is within ±1.00D of the emmetropia after PC pIOL.
The reduction in a refractive error is accompanied by a
great improvement in UDVA.
The majority of reported complications after ICL implan-
tation are cataract formation [44]. Guber et al. [45] reported
the rates of cataract formation 10 years after PC pIOL
implantation. The study included 133 eyes of 78 patients.
Cataract surgery was performed in 18 eyes at 10 years after
PC pIOL implantation. Alfonso et al. [46] retrospectively
analysed the prevalence of cataract after PC pIOL implanta-
tion. The study included 3240 eyes. The authors reported that
the incidence of cataract was low after PC pIOL implantation
at the 6-year follow-up. They found that the rate of cataract
was higher in patients with a high refractive error.
A suitably sized PC pIOL can prevent the alteration of the
anterior segment structures. An oversized PC pIOL can pro-
vide pupillary block, while an undersized lens increases the
risk for cataract development. Boxer Wachler and Vicente
[40] conducted a comparative study in which they used two
methods to select the length of PC pIOL in keratoconus
patients. One based on white-to-white distance and the other
on sulcus-to-sulcus distance. The authors found that both
methods provide adequate ﬁnal central PC pIOL vault.
Sulcus-to-sulcus method provided higher vault predictabil-
ity, although the diﬀerence between the 2 methods was not
statistically signiﬁcant.
An important issue for any refractive procedure in kera-
toconus is whether it could provide a cornea weakness, which
could increase the risk for disease progressions. Ali et al. [41]
carried out a comparative study to assess the changes in cor-
neal biomechanics after PC pIOL implantation form normal
and keratoconic patients. They found no signiﬁcant changes
in corneal hysteresis and corneal resistance factor after PC
pIOL implantation, neither in normal eyes nor in keratoco-
nic eyes. The authors pointed out that PC pIOL implantation
in keratoconic patients could be safer than corneal refractive
surgery, from a biomechanical point of view.
Despite the good visual and refractive outcomes reported,
it should be taken into consideration that pIOLs can correct
only spherical and cylindrical errors. It is very well docu-
mented that keratoconus induces a signiﬁcant increase in
HOAs [47, 48]. Keratoconus can have high levels of coma-
like aberrations and spherical aberrations, among others
[48], impacting negatively on the visual quality of the
patients. These HOAs are not corrected by pIOLs.
The success of this pIOL implantation requires knowl-
edge of the risk of progression of keratoconus, because of
the progression of keratoconus leading to refraction change,
and it could be a problem after pIOL implantation. Before
surgery, a careful exploration should be performed to analyze
whether signs of keratoconus progression are present.
2.3. Pseudophakic IOL. In keratoconic patients, the onset of
cataract and/or presbyopia contributes to further decrease
vision in already disabled patients. It is known that two of
the most common human ocular aﬄictions are presbyopia
and cataract [49]. Therefore, it seems evident that an impor-
tant proportion of patients with keratoconus will develop
3Journal of Ophthalmology
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age-related cataract and presbyopia. When a patient develops
presbyopia or cataract, the corneal refractive surgery or
phakic IOL implantation may not be the best option, being
the replacement of the crystalline lens with a pseudophakic
IOL the more proper approach.
Review of the literature was conducting using a combina-
tion of the following terms: “(keratoconus OR keratoconic)
AND (intraocular lens OR cataract).” The databases used
were PubMed, Web of Science, Embase, and Scopus. Once
again, in this section, we excluded the studies in which this
procedure was combined with other techniques. We found
18 articles, which met with our inclusion criteria.
Choosing the IOL power may be a challenge in keratoco-
nus patients. Several articles focused on that. Celikkol et al.
[50] suggested that videokeratography-derived K values
might be more accurate than standard keratometry to calcu-
late the IOL power. This study was carried out with only 2
eyes. Leccisotti [51] reported the outcomes after refractive
lens exchange in a prospective noncomparative study, in
which 34 eyes of 20 patients with stage I and II keratoconus
were included. They concluded that refractive exchange in
keratoconic eyes is a predictable procedure to correct myo-
pia. However, 32% of the cases required an IOL exchange
due to inaccurate IOL power calculation. Watson et al. [52]
retrospectively reviewed the refractive outcomes of 92 eyes
which underwent cataract surgery with implantation of a
spherical IOL. They concluded that the actual K value with
a target of low myopia is a proper option for spherical IOL
choice for eyes with a mean K of ≤55D. However, in the
keratoconus eye, in which the mean K is higher than
55D, the actual K values result in a large hyperopic error.
Thebpatiphat et al. [53] compared the SRKI, SRKII, and
SRK/T IOL formulas in patients with keratoconus and
suggested that the SRKII formula might provide the most
accurate IOL power in patients with mild keratoconus.
However, in moderate and severe keratoconus, IOL calcula-
tions were less accurate and no diﬀerences in calculation
formulas were found.
A source of error for IOL power calculation in keratoconic
patients is thedeterminationof theopticalpowerof the cornea.
Usually, the power of the cornea is estimated by considering
only the radius of the anterior surface and a simulated refrac-
tive keratometric index. This estimation could lead to inaccu-
racies in the calculation of total corneal power in keratoconic
eyes, where both the anterior and posterior surfaces of the cor-
nea are aﬀected. Tamaoki et al. [54] proposed to calculate the
real corneal power values by taking both the anterior and pos-
terior corneal curvature, using the current advanced technol-
ogy, which provides the posterior corneal curvature. Camps
et al. [55] introduced an approach for correcting the error in
the estimation of corneal power in keratoconus, by means of
a variable keratometric index that minimizes this error.
Despite the complexity of calculating IOL power in kera-
toconus, it should be considered that these patients may have
better tolerance to defocus than healthy patients. So some
residual refractive errors after IOL implantation can be better
tolerated [56].
Regarding visual outcomes, several previous studies
[57–64] have evaluated the results of replacement of lens
(either by refractive lens exchange or cataract extraction) by
a capsular bag toric intraocular lens (IOL). The ﬁrst three arti-
cles [57–59] were case reports, which showed encouraging
results. Subsequent case series studies [60–64] (from 12 to
23 eyes) reported a signiﬁcant improvement in UDVA,
CDVA, and refractive error (see Table 3). Recently, Meyer
et al. [65] described 7 cases in which a supplementary
sulcus-based toric IOL was implanted to compensate residual
astigmatism in keratoconus patients with prior cataract
surgery and spherical IOL implantation. They reported poor
results in terms of rotational stability.
Two studies presented the outcomes with multifocal toric
intraocular lens [66, 67]. Montano et al. [66] described two
cases, a form fruste keratoconus and a stable keratoconus.
Farideh et al. [67] evaluated the clinical results of toric
intraocular trifocal IOL in 10 eyes (5 patients) with mild
keratoconus. Both studies concluded that multifocal toric
IOL provides satisfactory results in mild and stable keratoco-
nus. However, this should be conﬁrmed with further studies
with a larger sample and a longer follow-up period.
Based on these previous studies, it seems that cataract
extraction with a toric IOL implantation in patients with
keratoconus may be a good option to restore the loss of
visual quality caused by cataract. However, it is important
to note that after cataract or clear lens extraction the risk
of retinal detachment could be higher. Furthermore, it is
important to bear in mind that even if the cataract is
removed and the refractive error is signiﬁcantly reduced
after this procedure, the corneal abnormalities are still
present. In Alió et al.’s study [62], the authors found that
patients with more regular corneas obtained higher
improvement of UDVA after surgery. Jaimes et al. [60]
reported signiﬁcant improvement in refractive error and
UDVA, but not for CDVA. These studies reveal that
although toric IOL implantation is a safe and eﬀective
option to improve refractive error and UDVA in cataractous
or clear lens keratoconic patients, the corneal abnormalities
may lessen the optimal restoration of the visual quality. Fur-
thermore, the success of this procedure requires knowledge
of the risk of progression of keratoconus, because of the
progression of keratoconus leading to refraction change,
and it could be a problem after IOL implantation. Before
surgery, a careful exploration should be performed to ana-
lyze whether signs of keratoconus progression are present.
However, a major risk factor for progression of keratoconus
is young age; in fact, the onset of keratoconus is usually at
puberty, and progression mainly occurs until the third of
fourth decade of life [2]. Therefore, in this age group, the
risk of keratoconus progression is minimal.
2.4. Intrastromal Corneal Ring Segments (ICRS). The types of
ICRS currently available can be grouped into two modalities:
(1) ring segments: Intacs and Intacs SK (Addition Technol-
ogy, Inc.) and Ferrara type (Keraring, Mediphachos, Inc.
and Ferrara Ring (AJL, Spain)); (2) Full-ring: MyoRing
(Dioptex, GmbH).
Intacs ICRS have an arc length of 150 degrees with an
inner diameter of 6.8mm. The thickness ranges from 0.25
to 0.45mm in 0.5mm steps. Intacs SK have an elliptical
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design; the optical zone is 6.0mm and is available in two
thicknesses (0.40mm and 0.45mm).
Ferrara-type ICRS has a triangular cross-section that
induces a prismatic eﬀect on the cornea. The apical diameter
of ICRS is 5.0mm ICRS (the ﬂat basis width is 0.6mm) or
6.0mm (the ﬂat basis width is 0.8mm), with variable thick-
nesses (0.15mm to 0.30mm with 0.05mm steps) and arc
lengths (90, 120, 150, and 210 degrees).
The MyoRing is available in a diameter range of 5–8mm
and a thickness range of 0.2–0.4mm in 0.02mm increments.
The width of the ring body is 0.5mm. The anterior surface is
convex, and the posterior surface is concave, with a radius of
curvature of 8.0mm.
ICRS implantation, both alone and in combination with
corneal collagen cross-linking, can be considered to regular-
ize the corneal shape and correct mild-moderate refractive
error. Most of the studies report a reduction in the spherical
equivalent of more than 2.00D after ICRS implantation
[68]. It should be considered that the shorter the arc length,
the greater the eﬀect on the refractive cylinder [69–72],
whereas a 210° arc length provides corneal ﬂattening and
reduces the myopia [69, 73, 74]. An important issue is
whether ICRS implantation halts or delays the progression
of keratoconus. This issue will be discussed below in the
combined procedure section.
3. Combined Procedures
The surgical procedures previously discussed may be inter-
esting treatment options in order to correct spherical and
cylindrical errors in stable keratoconus or keratoconus sus-
pects. It is very well documented that keratoconus induces
a signiﬁcant increase in HOAs [47, 48]. Keratoconus can
have high levels of coma-like aberrations and spherical
aberrations, among others [48], impacting negatively on the
visual quality of the patients. On the other hand, the progres-
sion of keratoconus leading to refraction and HOAs changes
and it could be a problem after any of the surgical procedure
previously described.
ICRS implantation and corneal collagen cross-linking
have showed to be a safe and eﬀective method to improve
the keratoconus corneal shape, improving visual quality,
and/or stop its progression [68, 75]. Keratoconus usually
has associated ametropia, and after ICRS implantation or
corneal CXL, most patients require contact lenses or spec-
tacle to correct residual refractive error. The following
sections review and discuss the results of the clinical stud-
ies in which ICRS implantation and corneal CXL were
combined with other surgical procedures to correct the
refractive error, improve visual quality, and/or stop or delay
the keratoconus progression.
3.1. Double Procedure (ICRS+ Intraocular Lens). To the best
of the author’s knowledge, there are no studies that evaluated
the ablative corneal refractive procedures to correct the resid-
ual refractive error after ICRS implantation. In this case, we
adopted the following terms to perform the literature search:
(keratoconus OR keratoconic) AND (intrastromal corneal
ring segment OR myoring OR Keraring OR Ferrara ICRS
OR icrs OR intacs) AND (lens OR ICL OR implantable
Collamer OR phakic intraocular lens). In this section, we
excluded the studies that include CXL as the third procedure,
because these studies will be discussed in other sections. We
found 10 articles, which met with our inclusion criteria.
3.1.1. ICRS+Phakic IOL. The ﬁrst study, which combined
ICRS and an IOL, was a case report published in 2003. Colin
and Velou [76] reported a case of Intacs implantation for
keratoconus followed by the implantation of an AC pIOL
to correct −8.25D of residual error. 2 months after AC pIOL
implantation, the UDVA and CDVA were 0.3 and 0.8
(decimal scale), respectively. Four years later, Kamburoğlu
et al. [77] published a case report of a bilateral keratoconus
in which Intacs were implanted in both eyes. Sixteen months
after Intacs implantation, AC pIOL toric (Artisan toric) was
inserted in both eyes to correct the residual myopic and astig-
matic refractive errors. At ﬁve months, the UDVA was 0.6
and 0.5 in the right and left eyes, respectively, and CDVA
0.7 in both eyes. The ﬁrst case series of this combined proce-
dure was published in 2007 [78]. El-Raggal and Abdel Fattah,
in a prospective study, evaluated the safety, eﬃcacy, and sta-
bility of sequential Intacs insertion and AC pIOL (Verisyse
pIOL) implantation in 8 keratoconus. The follow-up was 24
months. All eyes reached UDVA of 20/40 or better, and no
eyes lost lines of CDVA compared to preoperative. The
spherical equivalent at the last visit ranged from −1.75D
to +1.00D. In a prospective nonrandomized study comparing
simultaneous and sequential implantation of Intacs and AC
pIOL (Verisyse), Moshirfar et al. [79] reported that combined
insertion of Intacs and AC pIOL was safe and eﬀective in all
cases. They suggested that the outcomes of the simultaneous
implantation of the Intacs and AC pIOL in 1 surgery were
similar to the results obtained with sequential implantation
using 2 surgeries. Ferreira et al. [80] retrospectively analysed
the visual and refractive outcomes of 21 stable keratoconus
who had ICRS implantation (Intacs and Intacs SK) followed
by AC pIOL implantation (Artisan or Artiﬂex Toric) 6
months or later. For each of the two surgical procedures, both
UDVA and CDVA improved signiﬁcantly. After AC pIOL
implantation, 61.9% of the eyes gained two or more lines of
CDVA, and the spherical equivalent was within ±1.00D of
emmetropia in 90.5% of the eyes. Three studies [81–83]
evaluated the results of combined ICRS and PC pIOL implan-
tation in keratoconus. Coskunseven et al. [81] reported the
results of three eyes who had undergone PC pIOL (toric
ICL) implantation after Intacs implantation. The UDVA
and CDVA were improved in the three cases, and all three
were emmetropic within ±1.00D after combined procedure.
Alfonso et al. reported [82] for the ﬁrst time the results of this
combined procedure using Ferrara-type ICRS and perform-
ing the ICRS implantation using femtosecond laser. Their
prospective study comprised 31 patients (40 eyes) with kera-
toconus who had ICRS implantation followed 6 months later
by PC pIOL implantation with corneal relaxing incision. The
mean spherical equivalent decreased from −9.66± 6.96D
preoperatively to −1.20± 1.33D 6 months after PC pIOL
implantation. At the end of the follow-up, 65% of eyes were
within ±1.00D of the desired refraction and 45% were within
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±0.50D. Of the 40 eyes analyzed, 3 eyes lost 1 line of monoc-
ular CDVA, 9 eyes had no change, 7 eyes gained 1 line, 10 eyes
gained 2 lines, and 11 eyes gained more than 2 lines. The
safety index (ratio of postoperative to preoperative monocu-
lar CDVA) 6months after PC pIOL was 1.28, and the eﬃcacy
index (mean postoperative UDVA/mean preoperative
CDVA) was 0.88. Navas et al. [83] in their retrospective study
also concluded that combined treatment of keratoconus with
ICRS and a pIOL or a toric pIOL was a safe and eﬀective
procedure for high refractive error correction induced by
keratoconus in selected patients.
Based on the encouraging outcomes, it seems that
sequential ICRS and pIOL implantation provides good visual
and refractive outcomes, suggesting that the procedure is
predictable for refractive correction of keratoconus. Combin-
ing ICRS with pIOLs may improve visual outcomes by
combining the eﬀects of ICRS in improving corneal shape
with those of pIOLs in correcting spherical and cylindrical
refractive errors. Any type of ICRS can be combined with
any type of pIOL. ICRS and pIOL can be implanted simulta-
neously in one surgery, or sequentially in two surgeries.
Although it has been suggested that both possibilities (simul-
taneous and sequential implantation) provide similar results
[79], in sequential procedure, keratometry (K) readings can
be taken after ICRS insertion, which theoretically ensures
better prediction of the pIOL power before implantation.
3.1.2. ICRS+Pseudophakic IOL. A sequential procedure has
also been studied for the combined treatment of cataract
and keratoconus [56, 84]. Alfonso et al. [56] reported the
long-term results of sequential implantation of the Ferrara-
type ICRS and IOL implantation in 70 eyes with keratoconus
and cataract. The mean UDVA (logMAR scale) was 1.08±
0.24 preoperatively, 0.95± 0.31 six months after ICRS
implantation, and 0.44± 0.29 six months after IOL implanta-
tion. The CDVA changed from 0.35± 0.23 (logMAR) before
surgery to 0.28± 0.22 six months after Ferrara-type ICRS
implantation and to 0.11± 0.16 six months after IOL implan-
tation. Both the UDVA and CDVA were stable over the post-
operative period of the second procedure. The spherical
equivalent and the refractive cylinder declined steeply after
IOL implantation and were also stable over the postoperative
period. They concluded that sequential Ferrara-type ICRS
and IOL implantation provides good visual and refractive
outcomes, being an eﬀective, safe, predictable, and stable
procedure for the treatment of patients with keratoconus
and cataract. Furthermore, the authors suggested that the
ICRS implantation before IOL implantation could help in
strengthening and/or reshaping the magnitude of the associ-
ated refractive error. The shape of the cornea may play an
important role in the calculation of the IOL power. In less
deformed corneas, more predictable results for the calcula-
tion of the IOL power should be expected. Hence, probably,
the ICRS implantation before IOL implantation could help
with IOL power calculations, because ICRS implantation
improves the shape of the cornea, and it could help obtain
a more accurate central corneal power and estimate the eﬀec-
tive lens position in a better way. However, this hypothesis
should be studied in futures studies.
It should be noted that the success of any sequential
procedure (ICRS and pIOL or IOL) requires knowing when
the refraction is stable after ICRS insertion and whether the
keratoconus progression has been halted. There is debate
and controversy about whether ICRS halts or delays the
progression of keratoconus. Bedi et al. [85] reported on
105 eyes with Intacs over ﬁve years and found that 93 per
cent of eyes with preoperative progressive keratoconus
showed no postoperative progression. Long-term results of
Ferrara-type ICRS implantation have been reported by
Torquetti et al. in two studies [86, 87], one with a ﬁve-
year follow-up [86] and the other with a ten-year follow-
up [87]. They found that the refractive and visual outcomes
were stable over the follow-up period. Progression of
keratoconus at the moment of the surgery was an inclusion
criterion in both studies. Fernández-Vega Cueto et al. [88]
and Lisa et al. [74] also reported that Ferrara-type ICRS
provides stable visual and refractive outcomes over 5- and
3-year follow-up, respectively. In Fernández-Vega Cueto’s
study [88], the results were stable even in young patients
where the risk of keratoconus progression over the follow-
up period is higher.
Vega-Estrada et al. [89, 90] carried out two studies in
which they analysed the ﬁve-year long-term eﬀects of ICRS
implantation in both, nonprogressive keratoconus [89] and
progressive keratoconus [90]. The authors concluded from
the ﬁrst study that the changes induced by ICRS are stable
over a long period in patients with no evidence of keratoco-
nus progression at the time of surgery [89]. In their second
study [90], they examined the outcomes of ICRS implanta-
tion in young patients showing evidence of keratoconus
progression and found that although ICRS implantation
improved the visual and refractive outcomes in the short
term, there was regression in the long term, which suggests
that this procedure is not stable in young patients with evi-
dence of keratoconus progression. However, it is important
to note that this study had certain limitations. It was carried
out on a total of 18 eyes, of which 13 eyes were implanted
with Intacs ICRS (10 with the mechanical procedure and 3
with femtosecond), and 5 eyes were implanted with
Ferrara-type ICRS (4 with femtosecond technology and 1
with the mechanical procedure). In addition, the keratoconus
included in this study showed very strong progression of the
disease (the mean K reading increased 3.17D and the mean
spherical equivalent 1.86D in 6 months immediately prior
to surgery).
Another important aspect to know whether any proce-
dure is able to halt or delay the disease progression is how
to document the keratoconus progression. According to
Global Consensus on Keratoconus and Ectatic Diseases
(2015), there is no consistent or clear deﬁnition of ectasia
progression [91]. This panel deﬁned progression by a consis-
tent change in at least two of the following parameters: steep-
ening of the anterior corneal surface, steepening of the
posterior corneal surface, and/or thinning or changes in the
pachymetric rate of change; nevertheless, the panel also
agreed that speciﬁc quantitative data to deﬁne progression
is lacking. Duncan et al. [92] published an interesting article
in which showed the limitations of these clinical parameters
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to diagnose progression of keratoconus. They proposed a
new software program to detect keratoconus progression.
In any case, it would be appropriate to conduct further
studies because, as it will be discussed, a triple procedure
(combining corneal cross-linking with ICRS implantation
and intraocular lens or corneal refractive surgery) might be
another alternative.
3.2. Corneal CXL. Corneal CXL is a minimally invasive
procedure, which aims to increase the mechanical and
biomechanical stability of the cornea. It is a photooxidative
procedure consisting of combined application of riboﬂavin
(vitamin B2) and ultraviolet A (UVA) light of 370 nm. The
standard protocol for CXL was reported by Wollensak et al.
[93] (it is currently known as the Dresden protocol for
CXL). The corneal epithelium is removed, and riboﬂavin
0.1% solution is instilled for 30 minutes before UVA
exposure. UVA irradiation is performed for an additional
30-minute period. High-ﬂuency CXL and transepithelial
CXL are variations of this technique, which aim to shorten
the exposure time to UVA light and/or reduce patient
discomfort and minimize potential complications.
There are many combination procedures such as corneal
CXL and excimer laser surgery and corneal CXL and intraoc-
ular lens implantation reported in the literature aiming at
therapeutic and refractive eﬀect. The combined procedure
of corneal CXL and ICRS implantation has been also studied
in diﬀerent articles. The main purpose of this combination is
to improve the keratoconus corneal shape and halt its pro-
gression. As we explained in ICRS section, this combination
can be used to correct mild-moderate refractive error, but
not moderate or high refractive error. Because of this review
focuses on the surgical approaches for therapeutic and refrac-
tive treatment of keratoconus, this combination has not been
included in this section. The last section analyses the results
of triple procedures (ICRS implantation and corneal CXL
were combined with other surgical procedures).
3.2.1. Double Procedure (Corneal CXL+Corneal Refractive
Surgery). In this section, the review of the literature was con-
ducting using a combination of the following terms: “(kerato-
conus OR keratoconic) AND (crosslinking or CXL) AND
(LASIK or PRK).” 25 studies were analysed. Kanellopoulos
and Binder [94] were the ﬁrst to attempt this combination
procedure. They reported the case of a 26-year-old male
patient with bilateral progressive keratoconus who had
topography-guided PRK 12 months after corneal CXL in the
left eye. 18 months after topography-guided PRK, the UDVA
was 20/20 and CDVA was 20/15 with no evidence of disease
progression. The authors concluded that this combined pro-
cedure seemed to be an eﬀective method for the treatment
of keratoconus. The authors also suggested that the nomo-
gram for the laser ablation should be adjusted in patients
who underwent corneal CXL. They pointed out that the more
rigid cornea might have an ablation rate diﬀerent from that of
normal cornea. Subsequent cohort studies reported the out-
comes of combined topography or wavefront-guided PRK
and corneal CXL in keratoconic patients [95–112]. The
results of these studies showed an UDVA after this combined
procedure between 0.7 and −0.01 logMAR (with most of the
studies where data are available reporting UDVA> 0.4 log-
MAR), CDVA ranging between 0.2 and −0.04 logMAR, and
the spherical equivalent between −2.80 and +0.05D. No evi-
dence of disease progression was reported after a follow-up
period ranging between 3 to 68 months. Furthermore, it
has been reported in a retrospective analysis of 53 keratoco-
nic eyes that distribution of epithelial thickness becomes
more even after this combined treatment [113]. Fadlallah
et al. [114] in a retrospective study reported that conven-
tional PRK and corneal CXL were eﬀective and safe options
for correcting mild refractive error and improving visual
acuity in early stable keratoconus. These favourable
refracto-therapeutic results are accompanied by an improve-
ment in the self-reported quality of life in keratoconus
patients [110, 112, 115, 116]. It appears that cone location
may have a signiﬁcant impact on the outcomes of this com-
bined procedure. A prospective, comparative case series
study found that the visual results were superior in cone
located within the central 2mm zone than in cones located
outside the central 2mm zone [106].
Four prospective, case series studies compared the
results of corneal CXL alone with combined simulta-
neous topography-guided PRK followed by corneal CXL
[102, 104, 108, 111]. All of them agreed that the combined
procedure provides better refractive and visual results
than corneal CXL alone and similar results regarding
postoperative stability.
Two prospective, comparative case series studies [96, 112]
addressed the time interval between the 2 procedures
(simultaneous versus sequential) and reached disparate
results. In Kanellopoulos [96] study, the simultaneous
approach provided superior visual and refractive results,
whereas Abou Samra et al. [112] found comparable objective
and subjective outcomes between the two options. Theoreti-
cally, simultaneous approach could provide more predictable
refractive outcomes, because the ablation is performed before
the corneal CXL. The ablation rate in a strengthened cornea
by CXL is currently unknown. By contrast, it has been
reported that the simultaneous procedure aﬀects keratocyte
density signiﬁcantly [117, 118]. This ﬁnding could be a conse-
quence of the sequence. The simultaneous procedure implies
ablation of Bowman’s membrane together with the epithe-
lium before CXL treatment. So perhaps this could lead to a
deeper penetration of riboﬂavin into the cornea [117, 118].
Further studies are needed to knowwhich is themost eﬀective
and safe procedure.
Important considerations for this combined procedure
are ablation depth and postoperative corneal thickness. Most
of the studies recommended a maximum ablation depth of
50μm and a minimal postoperative corneal thickness of no
less than 350μm. So, in keratoconus cases with a
moderate-high ammetropia and/or thin cornea, this com-
bined procedure would not be capable to correct the full
refractive preoperative error.
3.2.2. Double Procedure (Corneal CXL+ Intraocular Lenses).
The combination of corneal CXL and IOL implantation is
another alternative to stabilize the keratoconus and correct
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the residual refractive error. In this case, we adopted the
following terms to perform the literature search: “(keratoco-
nus OR keratoconic) AND (crosslinking or CXL) AND
(lens OR ICL).”
(1) Corneal CXL+Phakic IOL. The combination of corneal
CXL and PC pIOL (toric ICL) implantation was ﬁrst reported
by Kymionis et al. [119]. A 29-year-old woman with progres-
sive keratoconus underwent toric PC pIOL implantation 12
months after corneal CXL. At 3 months, the UDVA rose
from counting ﬁngers to 20/40 and the CDVA improved
from 20/100 to 20/30. Furthermore, no intraoperative or
postoperative complications were observed. The authors
concluded that this combined procedure in a 2-step proce-
dure seemed to be an eﬀective method for correcting kerato-
conus in patients with high myopia and astigmatism.
Favourable outcomes have since been reported in kera-
toconic patients who underwent this combined procedure
(corneal CXL and PC pIOL implantation) [37, 120–122],
with all studies reporting that PC pIOLs or toric PC pIOLs
were a predictable, safe, and eﬀective way to correct refractive
error in patients with keratoconus following corneal CXL.
Fadlallah et al. [120] evaluated the safety and clinical out-
comes of toric PC pIOL implantation 6 months after corneal
CXL in 16 eyes of 10 patients. Six months after toric PC pIOL
implantation, the mean of spherical equivalent decreased
from −7.24± 3.53 to −0.89± 0.76D and the mean cylinder
dropped from 2.64± 1.28 to −1.16± 0.64D. Shaﬁk Shaheen
et al. [121] reported a 3-year-long-term clinical study to
assess the predictability, eﬃcacy, safety, and stability in
patients who received a toric PC pIOL after corneal CXL in
early stage keratoconus. The study included 16 eyes. The
mean spherical equivalent after toric PC pIOL was less
than −0.25D. Antonios et al. [122] evaluated the long-term
safety and clinical outcomes of progressive keratoconus
patients who had sequential corneal CXL followed by toric
PC pIOL implantation after 6 months. The study included
30 eyes. 6 months after corneal CXL, no change in visual acu-
ity or refraction was obtained. Twelve months after toric PC
pIOL implantation, the mean spherical equivalent improved
from −6.96± 3.68D preoperatively to −0.83± 0.76D. The
mean cylinder, in turn, varied from 2.95± 1.40D to 1.03±
0.60D. Both UDVA and CDVA improved after toric PC
pIOL implantation, and the values were maintained during
the follow-up.
Implantation of the AC pIOL following corneal CXL is
another possibility to correct the refractive error. Izquierdo
et al. [123] in prospective study evaluated the safety, eﬃcacy,
and stability of the AC pIOL (Artiﬂex) implantation 6
months after corneal CXL in progressive keratoconus. The
results of this case series study showed a signiﬁcant improve-
ment in visual acuity, keratometry, and refractive error, 6
months after AC pIOL implantation, and no intraoperative
or postoperative complications were reported. Güell et al.
[124] retrospectively reported long-term outcomes of com-
bined corneal CXL and toric AC pIOL (Artiﬂex or Artisan)
implantation, concluding that this is a safe and eﬀective
approach to correct myopic astigmatism in progressive mild
to moderate keratoconus.
(2) Corneal CXL+Pseudophakic IOL. Corneal CXL followed
by phacoemulsiﬁcation with IOL implantation (either by
refractive lens exchange or cataract extraction) has also been
studied [125, 126]. Spadea et al. [125] described two patients
with cataract and progressive keratoconus who underwent a
2-stage treatment: ﬁrst corneal CXL followed by phacoemul-
siﬁcation with IOL implantation. The time interval between
two procedures was at least 6 months. In both cases, UDVA
andCDVA improved after IOL implantation. In a prospective
study, Abou Samra et al. [126] evaluated the outcomes of a
corneal CXL followed by phacoemulsiﬁcation with toric IOL
implantation in 9 eyes diagnosed with progressive keratoco-
nus. The preoperative spherical equivalent was −8.11
± 1.76D improving to −0.91± 0.77D 12 months postopera-
tively. The UDVA (logMAR scale) rose from a preoperative
1.43± 0.51 preoperatively to a 12-month postoperative 0.30
± 0.09 logMAR. The CDVA, in turn, varied from 0.34± 0.12
to 0.24± 0.13. From these outcomes, the authors concluded
that this two-stage approach was a safe and eﬀective proce-
dure in terms of keratometric stability and visual and refrac-
tive outcomes in patients with keratoconus.
Based on these encouraging outcomes, it seems that cor-
neal CXL and IOL implantation (phakic and pseudophakic)
provides good visual and refractive outcomes, suggesting that
this combined procedure might be an eﬀective procedure for
stabilizing the disease and improving visual and refractive
outcomes. Despite these good outcomes, it should be taken
into consideration that this combination could stabilize the
disease, but only correct spherical and cylindrical errors.
Patients with poor CDVA because of irregular astigmatism
and/or HOAs would require an additional procedure to
improve the corneal shape.
3.3. Triple Procedure (ICRS AND Corneal CXL AND…). A 3-
stage procedure has been proposed to halt the ectatic process,
improve the corneal shape and visual acuity, and minimize
the residual refractive error. Five studies analysed the eﬃcacy
and safety of the triple procedure: corneal CXL, ICRS
implantation, and PRK [123–132]. All of these studies
reported signiﬁcant improvement in visual acuity, refraction,
and corneal shape. This triple procedure can be performed in
2-stage ICRS implantation followed by simultaneous PRK
and corneal CXL [127–130] or in a three-step procedure
ICRS implantation followed by corneal CXL and PRK 6
months later [131, 132].
Three studies evaluated the outcomes of patients treated
with the 3-stage procedure: ICRS implantation+ corneal
CXL+phakic IOL implantation. In a prospective case series
study, Coşkunseven et al. [133] evaluated this 3-stage proce-
dure in 14 eyes. The time interval among surgeries was 6
months. The mean manifest refraction spherical equivalent
decreased from −16.40± 3.56D to 0.80± 1.02D after the 3
combined treatments. The refractive outcomes were stable
in all eyes over 12 months of follow-up. There was a signiﬁ-
cant improvement in CDVA after the 3-stage procedure.
The authors concluded that this combined 3-stage approach
was eﬀective in improving functional vision and reducing
disease progression in keratoconic eyes. Jarade et al. [134]
retrospectively analysed 11 keratoconus who had 3-step
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ICRS implantation followed by CXL and then toric PC pIOL
implantation. The time interval between ICRS implantation
and CXL was 4 weeks and between CXL and toric PC pIOL
implantation was at least 6 months. The combined procedure
resulted in signiﬁcant improvements in UDVA and CDVA.
The spherical equivalent decreased from −9.70± 3.1D
to −0.58± 1.01D 6 months after toric PC pIOL implantation.
The authors also concluded that the 3-step procedure was
safe, eﬀective, and predictable in the treatment of selected
cases of keratoconus. Dirani et al. [135] retrospectively
examined the results of this triple procedure in 11 eyes with
moderate to severe keratoconus. They also found that the
UDVA, CDVA, and refractive error improved signiﬁcantly
after toric PC pIOl implantation.
Sideroudi et al. [136] assessed the impact of corneal CXL
on the material properties of ICRS. They found that an
amount of riboﬂavin solution was absorbed into the samples
of ICRS analyzed after CXL procedure. El-Raggal [137] eval-
uated the eﬀect of corneal CXL on femtosecond laser channel
creation for ICRS implantation. The results showed that the
laser power must be modiﬁed after CXL. The author sug-
gested that channel dissection and ICRS implantation should
be performed before or concurrent with CXL. These ﬁndings
should be taken into consideration when CXL is combined
with ICRS implantation.
Assaf and Kotb [138] proposed another possibility of tri-
ple procedure: simultaneous PRK and corneal CXL followed
by AC pIOL implantation. The time interval between
simultaneous PRK and CXL was 2–4 months. The study
included 22 eyes. The mean spherical equivalent was reduced
from −9.08± 2.5D preoperatively to −0.69± 0.67D postoper-
atively. The UDVA improved from 1.24± 0.49 to 0.37± 0.08
logMAR and CDVA from 0.69± 0.3 to 0.35± 0.01. The
authors concluded that this triple procedure improved and
stabilized visual performance in patients with keratoconus.
They proposed that large-scale studies with a longer follow-
up are needed to assess this approach.
4. Conclusion
Keratoconus patients present signiﬁcantly impaired quality
of life that deteriorates as the disease progresses [4, 5]. The
treatment used as well as the method to correct the refractive
error of these patients may also inﬂuence on the impact of the
disease on their quality of life [6, 12, 115, 116]. Keratoconus
was historically once considered a contraindication to refrac-
tive surgery. However, the range of refractive procedures
available now, as well as the advanced technology to accu-
rately diagnose and follow the keratoconus, opens a new
frontier in the keratoconus treatment by means of refractive
surgery. Generally, the visual rehabilitation for keratoconic
corneas requires addressing three concerns: halting the
ectatic process, improving corneal shape, and minimizing
the residual refractive error. The treatment would depend,
Keratoconus
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Figure 1: Decision tree treatment considering the stability or progression, the corrected distance visual acuity (CDVA), and the refractive
error. PRK= photorefractive keratectomy; pIOL= phakic intraocular lens; IOL= pseudophakic intraocular lens; ICRS = intrastromal
corneal ring segments; CXL = corneal collagen cross-linking. ∗If keratoconus is stable after ICRS implantation.
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among others factors, on each of these concerns and its inﬂu-
ence on the disease and quality of vision of the patient. That
is, keratoconus is progressing or not, the cornea shape is very
irregular with high level of HOAs and poor CDVA or not,
and ﬁnally the degree of associated ametropia. In this sense,
corneal CXL can slow down or halt the disease progression,
ICRS implantation can improve the corneal shape and hence
the visual quality and reduce the refractive error, PRK can
correct mild-moderate refractive error, and IOL can correct
from low to high refractive error associated with keratoco-
nus. Any of these surgical options can be performed alone
or combined with the other techniques depending on what
the case requires (strengthening or reshaping associated
refractive error). Figure 1 shows a decision tree treatment
considering the stability or progression, the CDVA, and the
refractive error.
Basing on the results published up to now, it seems that
the surgical techniques (both, when used alone and in
combination) provide safe and eﬀective results for the
refracto-therapeutic treatment in selected cases of keratoco-
nus. However, all these techniques should be considered
carefully as the follow-up periods of the relevant studies
are relatively short. Most of these studies are case series or
retrospective analysis, which include small number of cases.
In summary, although it could be considered that the
surgical option for the refracto-therapeutic treatment of the
keratoconus is a reality, controlled, randomized studies with
larger cohorts and longer follow-up periods are needed to
determinate which refractive procedure and/or sequence
are most suitable for each case.
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